情绪障碍治疗的患者通过使用各种其他方法治疗等也会导致异常的数量获得人体的重量,海拔在体内的葡萄糖水平,条件与高胰岛素血症、胰岛素抵抗和血脂异常(麦金太尔等,2008)。这是过去最常用的治疗方法之一,是用于许多情绪障碍患者。然而,一段时间,这是观察到大脑情绪障碍是不相关的,也是与其他一些症状,比如穷人葡萄糖稳态,抵抗胰岛素和体重的增加。同时,观察,GLP – 1受体在糖尿病不仅可以是有益的,但在神经细胞在体内的生长产生影响。根据最近的研究,也发现许多神经元相关缺陷是由于减少引起肽(GLP-1)等活性胰高糖素在体内(Ashrafian等,2013)。从实验中发现,glp – 1在大脑和受体位于他们也有重要的对人类行为的影响。最近的证据也表明这是glp – 1在许多有重要作用的受体的活动,如睡眠模式和其他抗炎和neuropositive活动。同时,它被发现是glp – 1在减少受体有助于β淀粉样肽的水平和氧化损伤大脑。
Mood disorder treatment in the patients by using various other methods for treatment also leads to the number of abnormalities such as the gain the weight of the human body, the elevation in the level of glucose in the body, the conditions related to hyperinsulinemia, resistance against insulin and dyslipidemia (McIntyre et al, 2008). This was one of the most used treatments in the past and was used for many mood disorder patients. However, over the period of time, it was observed that mood disorder is just not related to the brain and is also linked to a number of other symptoms such as the poor glucose homeostatic, resistance against the insulin and gain of weight. Also, it was observed that GLP 1 receptors not only can be beneficial in diabetes but has an impact in the growth of neurons in the body as well. According to the recent studies, it was also observed that many neuron related defects are caused due to the reduction in the active Glucagon like Peptide (GLP-1) in the body (Ashrafian et al, 2013). It was found from the experiments that the GLP-1 receptors are located in the brain and they also have a significant effect on the human behavior. Recent evidences also suggested that it was the GLP-1 receptors which have a significant role in a number of activities such as sleep patterns and other anti-inflammatory and neuropositive activities. Also, it was found that it is the GLP-1 receptor which helps in the reduction of the levels of Amyloid beta peptide and the oxidative damage in the brain.